Johnson & Johnson (JNJ) — closed signal from February 28, 2026
Partial Published before the outcome was known, scored automatically when the window closed on May 29, 2026.
Predicted vs. what happened
What happened
Reached 16% of the predicted growth at its peak, without hitting the target.
The thesis — published February 28, 2026
This is a short-term hold in healthcare because the company is steady and often attracts buyers when markets are picky. Coverage that focuses on valuation and its drug pipeline helps keep interest, so people may buy small dips. Expect slow, steady gains rather than rapid moves. Be careful with size and trim gains; risks include lawsuits, trial setbacks, or a market shift away from defensive stocks.
Primary drivers
- Big healthcare name often attracts buyers during market weakness
- Positive talk about value and new drugs keeps investor interest
- Price action suits a buy-the-dip approach rather than fast trades
- Lower volatility helps stabilize a portfolio in choppy markets
How it played out
JNJ: target was not reached
Lyra published JNJ on 2026-02-28 at 248.43 as a short-term healthcare hold. The thesis expected 8% growth to 268.30. It pointed to a large healthcare name attracting buyers during market weakness, positive talk about value and new drugs, buy-the-dip price action, and lower volatility in choppy markets.
Inside the window, JNJ peaked at 251.71 on 2026-03-02, a 1.3% gain. It stayed below the 268.30 target and never reached it. By 2026-05-29, it ended at 225.33. The thesis missed on price, even though there was a small early move in the expected direction.
What happened during the window
On 2026-04-14, Johnson & Johnson reported first-quarter sales of $24.06 billion and raised its full-year forecast. MarketWatch also reported on 2026-04-14 that the company raised its 2026 sales and earnings guidance after first-quarter results.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.